Literature DB >> 10082525

The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.

A Elkeles1, T Juven-Gershon, D Israeli, S Wilder, A Zalcenstein, M Oren.   

Abstract

The p53 tumor suppressor gene is mutated in over 50% of human cancers, resulting in inactivation of the wild-type (wt) p53 protein. The most notable biochemical feature of p53 is its ability to act as a sequence-specific transcriptional activator. Through use of the suppression subtractive hybridization differential screening technique, we identified c-fos as a target for transcriptional stimulation by p53 in cells undergoing p53-mediated apoptosis. Overexpression of wt p53 induces c-fos mRNA and protein. Moreover, in vivo induction of c-fos in the thymus following whole-body exposure to ionizing radiation is p53 dependent. p53 responsiveness does not reside in the basal c-fos promoter. Rather, a distinct region within the c-fos gene first intron binds specifically to p53 and confers upon the c-fos promoter the ability to become transcriptionally activated by wt p53. Identification of c-fos as a specific target for transcriptional activation by p53 establishes a direct link between these two pivotal regulatory proteins and raises the possibility that c-fos contributes to some of the biological effects of p53.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082525      PMCID: PMC84052          DOI: 10.1128/MCB.19.4.2594

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

1.  Repression of the basal c-fos promoter by wild-type p53.

Authors:  N Kley; R Y Chung; S Fay; J P Loeffler; B R Seizinger
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

Review 2.  The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation.

Authors:  P Angel; M Karin
Journal:  Biochim Biophys Acta       Date:  1991-12-10

3.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

4.  Specific interaction between the p53 cellular tumour antigen and major heat shock proteins.

Authors:  O Pinhasi-Kimhi; D Michalovitz; A Ben-Zeev; M Oren
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

5.  Wild-type p53 can down-modulate the activity of various promoters.

Authors:  D Ginsberg; F Mechta; M Yaniv; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

6.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

Authors:  E Yonish-Rouach; D Resnitzky; J Lotem; L Sachs; A Kimchi; M Oren
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

7.  Frequent p53 mutations in chemically induced murine fibrosarcoma.

Authors:  O Halevy; J Rodel; A Peled; M Oren
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

8.  p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

Authors:  T Mitsudomi; S M Steinberg; M M Nau; D Carbone; D D'Amico; S Bodner; H K Oie; R I Linnoila; J L Mulshine; J D Minna
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

9.  Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest.

Authors:  Y Barak; M Oren
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

10.  mdm2 expression is induced by wild type p53 activity.

Authors:  Y Barak; T Juven; R Haffner; M Oren
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

View more
  19 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

2.  The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.

Authors:  Koji Nakade; Hong Zheng; Gitali Ganguli; Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  Platelet-activating factor induces proliferation in differentiated keratinocytes.

Authors:  Astrid J Feuerherm; Katarina M Jørgensen; Randi M Sommerfelt; Live E Eidem; Astrid Lægreid; Berit Johansen
Journal:  Mol Cell Biochem       Date:  2013-08-24       Impact factor: 3.396

4.  Phenotype anchoring in zebrafish reveals a potential role for matrix metalloproteinases (MMPs) in tamoxifen's effects on skin epithelium.

Authors:  Sean M Bugel; Leah C Wehmas; Jane K La Du; Robert L Tanguay
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-18       Impact factor: 4.219

5.  UV-Induced stabilization of c-fos and other short-lived mRNAs.

Authors:  C Blattner; P Kannouche; M Litfin; K Bender; H J Rahmsdorf; J F Angulo; P Herrlich
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

6.  Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia.

Authors:  Baoman Li; Lu Dong; Bing Wang; Liping Cai; Ning Jiang; Liang Peng
Journal:  Neurochem Res       Date:  2012-06-19       Impact factor: 3.996

7.  MCG10, a novel p53 target gene that encodes a KH domain RNA-binding protein, is capable of inducing apoptosis and cell cycle arrest in G(2)-M.

Authors:  J Zhu; X Chen
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function.

Authors:  L Palanikumar; Laura Karpauskaite; Mohamed Al-Sayegh; Ibrahim Chehade; Maheen Alam; Sarah Hassan; Debabrata Maity; Liaqat Ali; Mona Kalmouni; Yamanappa Hunashal; Jemil Ahmed; Tatiana Houhou; Shake Karapetyan; Zackary Falls; Ram Samudrala; Renu Pasricha; Gennaro Esposito; Ahmed J Afzal; Andrew D Hamilton; Sunil Kumar; Mazin Magzoub
Journal:  Nat Commun       Date:  2021-06-25       Impact factor: 14.919

9.  MLL2 is required in oocytes for bulk histone 3 lysine 4 trimethylation and transcriptional silencing.

Authors:  Claudia V Andreu-Vieyra; Ruihong Chen; Julio E Agno; Stefan Glaser; Konstantinos Anastassiadis; A Francis Stewart; Martin M Matzuk
Journal:  PLoS Biol       Date:  2010-08-17       Impact factor: 8.029

10.  Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells.

Authors:  Zhi-Wei Yu; Peng Zhao; Ming Liu; Xin-Shu Dong; Ji Tao; Xue-Qin Yao; Xin-Hua Yin; Yu Li; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.